Active, Not Recruiting
A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)
NCT06548100
- Conditions
- Body Weight, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diabetes Mellitus, +28 more
- Locations
-
- National Institutes of Health Bethesda, Maryland, United States
- University of Michigan Ann Arbor, Michigan, United States